Rhythm Pharmaceuticals, Inc. RYTM Return on invested capital

Return on invested capital at other companies

Eli LillyLLY

39.7%+10.3pp

Aardvark Therapeutics, Inc.AARD

-99.8%—

Viking TherapeuticsVKTX

-59.2%-292pp

Mirum Pharmaceuticals, Inc.MIRM

-43.3%—

TG TherapeuticsTGTX

21.4%-4.5pp

Neurocrine BiosciencesNBIX

17.5%+5.1pp

FAQ

What is Rhythm Pharmaceuticals, Inc.'s return on invested capital?

Rhythm Pharmaceuticals, Inc. (RYTM) reported return on invested capital of -197.9% in Q1 2026.

How has Rhythm Pharmaceuticals, Inc.'s return on invested capital changed year-over-year?

Rhythm Pharmaceuticals, Inc.'s return on invested capital increased by 79.6% year-over-year, from -967.9% to -197.9%.

What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s return on invested capital?

Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s return on invested capital has grown at a 11.4% compound annual growth rate (CAGR), from -92.1% to -157.9%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.